Up-front use of aromatase inhibitors as adjuvant therapy for breast cancer: the emperor has no clothes
J Clin Oncol
.
2009 Feb 20;27(6):840-2.
doi: 10.1200/JCO.2008.19.5594.
Epub 2009 Jan 12.
Authors
Bostjan Seruga
1
,
Ian F Tannock
Affiliation
1
Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada.
PMID:
19139426
DOI:
10.1200/JCO.2008.19.5594
No abstract available
MeSH terms
Aromatase Inhibitors / administration & dosage*
Breast Neoplasms / drug therapy*
Breast Neoplasms / surgery
Disease-Free Survival
Female
Humans
Neoadjuvant Therapy
Survival Analysis
Substances
Aromatase Inhibitors